ATM regulates Cdt1 stability during the unperturbed S phase to prevent re-replication

Cell Cycle

Volumn 13, Issue 3, 2014, Pages 471-481

  Iwahori, Satoko ^a   Kohmon, Daisuke ^b   Kobayashi, Junya ^c   Tani, Yuhei ^b   Yugawa, Takashi ^a   Komatsu, Kenshi ^c   Kiyono, Tohru ^a   Sugimoto, Nozomi ^b   Fujita, Masatoshi ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

ATM; Cdt1; Control of cell cycle progression; Dna damage and repair mechanisms

Indexed keywords

ATM PROTEIN; CELL CYCLE PROTEIN 6; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; NIBRIN; PROTEIN KINASE B; REPLICATION LICENSING FACTOR CDT1; S PHASE KINASE ASSOCIATED PROTEIN 2; UBIQUITIN PROTEIN LIGASE; ATM PROTEIN, HUMAN; CDT1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA; NBN PROTEIN, HUMAN; NUCLEAR PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIVISION; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE SILENCING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STABILITY; CELL LINE; DNA REPLICATION; GENETICS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE PROTEINS; CELL LINE; DNA; DNA REPLICATION; GENE SILENCING; GENOMIC INSTABILITY; HUMANS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEOLYSIS; S PHASE; S-PHASE KINASE-ASSOCIATED PROTEINS; SIGNAL TRANSDUCTION;

EID: 84896890103     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.27274     Document Type: Article

References (46)

1. Bartek J, Lukas J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 2003; 3:421-9; PMID:12781359; http://dx.doi.org/10.1016/ S1535-6108(03)00110-7
2. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004; 432:316-23; PMID:15549093; http://dx.doi.org/10.1038/nature03097
3. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. Toward maintaining the genome: DNA damage and replication checkpoints. Annu Rev Genet 2002; 36:617-56; PMID:12429704; http://dx.doi.org/10.1146/annurev.genet.36.060402.113540
4. Cam H, Easton JB, High A, Houghton PJ. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. Mol Cell 2010; 40:509-20; PMID:21095582; http://dx.doi.org/10.1016/j.molcel.2010.10. 030
5. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010; 330:517-21; PMID:20966255; http://dx.doi.org/10. 1126/science.1192912
6. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C. A cytoplasmic ATM-TRAF6-cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NFeκB activation. Mol Cell 2010; 40:63-74; PMID:20932475; http://dx.doi.org/10.1016/j.molcel.2010.09.008
7. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499-506; PMID:12556884; http://dx.doi.org/10.1038/nature01368
8. Fujita M. Cdt1 revisited: complex and tight regulation during the cell cycle and consequences of deregulation in mammalian cells. Cell Div 2006; 1:22; PMID:17042960; http://dx.doi.org/10.1186/1747-1028-1-22
9. Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y, Wagle N, Hwang DS, Dutta A. A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 2003; 11:997-1008; PMID:12718885; http://dx.doi.org/10.1016/S1097-2765(03) 00099-6
10. Sugimoto N, Kitabayashi I, Osano S, Tatsumi Y, Yugawa T, Narisawa-Saito M, Matsukage A, Kiyono T, Fujita M. Identification of novel human Cdt1-binding proteins by a proteomics approach: proteolytic regulation by APC/CCdh1. Mol Biol Cell 2008; 19:1007-21; PMID:18162579; http://dx.doi.org/10.1091/mbc.E07-09-0859
11. Sugimoto N, Yoshida K, Tatsumi Y, Yugawa T, Narisawa-Saito M, Waga S, Kiyono T, Fujita M. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells. J Cell Sci 2009; 122:1184-91; PMID:19339550; http://dx.doi.org/10.1242/jcs.041889
12. Lee AY, Liu E, Wu X. The Mre11/Rad50/Nbs1 complex plays an important role in the prevention of DNA rereplication in mammalian cells. J Biol Chem 2007; 282:32243-55; PMID:17715134; http://dx.doi.org/10.1074/jbc.M705486200
13. Tatsumi Y, Sugimoto N, Yugawa T, Narisawa-Saito M, Kiyono T, Fujita M. Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. J Cell Sci 2006; 119:3128-40; PMID:16835273; http://dx.doi.org/10.1242/jcs.03031
14. Nishitani H, Taraviras S, Lygerou Z, Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. J Biol Chem 2001; 276:44905-11; PMID:11555648; http://dx.doi.org/10.1074/jbc.M105406200
15. Kim J, Wong PK. Oxidative stress is linked to ERK1/2-p16 signaling-mediated growth defect in ATM-deficient astrocytes. J Biol Chem 2009; 284:14396-404; PMID:19321450; http://dx.doi.org/10.1074/jbc.M808116200
16. Ito K, Takubo K, Arai F, Satoh H, Matsuoka S, Ohmura M, Naka K, Azuma M, Miyamoto K, Hosokawa K, et al. Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J Immunol 2007; 178:103-10; PMID:17182545
17. Higa LA, Mihaylov IS, Banks DP, Zheng J, Zhang H. Radiation-mediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat Cell Biol 2003; 5:1008-15; PMID:14578910; http://dx.doi.org/10.1038/ncb1061
18. Reaper PM, Griffiths MR, Long JM, Charrier JD, Maccormick S, Charlton PA, Golec JM, Pollard JR. Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR. Nat Chem Biol 2011; 7:428-30; PMID:21490603; http://dx.doi.org/10.1038/nchembio.573
19. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 2003; 22:5612-21; PMID:14532133; http://dx.doi.org/10.1093/emboj/cdg541
20. Hu J, McCall CM, Ohta T, Xiong Y. Targeted ubiquitination of CDT1 by the DDB1-CUL4A-ROC1 ligase in response to DNA damage. Nat Cell Biol 2004; 6:1003-9; PMID:15448697; http://dx.doi.org/10.1038/ncb1172
21. Nishitani H, Sugimoto N, Roukos V, Nakanishi Y, Saijo M, Obuse C, Tsurimoto T, Nakayama KI, Nakayama K, Fujita M, et al. Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis. EMBO J 2006; 25:1126-36; PMID:16482215; http://dx.doi.org/10.1038/sj.emboj.7601002
22. Arias EE, Walter JC. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat Cell Biol 2006; 8:84-90; PMID:16362051; http://dx.doi.org/10.1038/ncb1346
23. Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8:438-49; PMID:18500245; http://dx.doi.org/10.1038/nrc2396
24. Viniegra JG, Martínez N, Modirassari P, Hernández Losa J, Parada Cobo C, Sánchez-Arévalo Lobo VJ, Aceves Luquero CI, Alvarez-Vallina L, Ramón y Cajal S, Rojas JM, et al. Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 2005; 280:4029-36; PMID:15546863; http://dx.doi.org/10.1074/jbc. M410344200
25. Khalil A, Morgan RN, Adams BR, Golding SE, Dever SM, Rosenberg E, Povirk LF, Valerie K. ATM-dependent ERK signaling via AKT in response to DNA double-strand breaks. Cell Cycle 2011; 10:481-91; PMID:21263216; http://dx.doi.org/10.4161/cc.10.3.14713
26. Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M, Rigoreau L, Menear KA, et al. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther 2009; 8:2894-902; PMID:19808981; http://dx.doi.org/10.1158/1535-7163.MCT-09-0519
27. Li Y, Yang DQ. The ATM inhibitor KU-55933 suppresses cell proliferation and induces apoptosis by blocking Akt in cancer cells with overactivated Akt. Mol Cancer Ther 2010; 9:113-25; PMID:20053781; http://dx.doi.org/10.1158/1535- 7163.MCT-08-1189
28. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 2009; 11:397-408; PMID:19270695; http://dx.doi.org/10.1038/ncb1847
29. Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adeno-carcinoma cells. Cancer Res 2007; 67:4149-56; PMID:17483325; http://dx.doi.org/10.1158/0008-5472.CAN-06-4484
30. Barré B, Perkins ND. A cell cycle regulatory network controlling NFkappaB subunit activity and function. EMBO J 2007; 26:4841-55; PMID:17962807; http://dx.doi.org/10.1038/sj.emboj.7601899
31. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH, Yang WL, Erdjument-Bromage H, Nakayama KI, Nimer S, et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 2009; 11:420-32; PMID:19270694; http://dx.doi.org/10.1038/ncb1849
32. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004; 428:194-8; PMID:15014503; http://dx.doi.org/10.1038/ nature02381
33. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature 2004; 428:190-3; PMID:15014502; http://dx.doi.org/10.1038/nature02330
34. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14:381-95; PMID:11882383; http://dx.doi.org/10.1016/S0898-6568(01)00271-6
35. Santi SA, Lee H. Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells. PLoS One 2011; 6:e14614; PMID:21297943; http://dx.doi.org/10. 1371/journal.pone.0014614
36. Lindsley CW, Zhao Z, Leister WH, Robinson RG, Barnett SF, Defeo-Jones D, Jones RE, Hartman GD, Huff JR, Huber HE, et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg Med Chem Lett 2005; 15:761-4; PMID:15664853; http://dx.doi.org/10.1016/j.bmcl.2004.11.011
37. Saxena S, Dutta A. Geminin-Cdt1 balance is critical for genetic stability. Mutat Res 2005; 569:111-21; PMID:15603756; http://dx.doi.org/10.1016/ j.mrfmmm.2004.05.026
38. Verdun RE, Crabbe L, Haggblom C, Karlseder J. Functional human telomeres are recognized as DNA damage in G2 of the cell cycle. Mol Cell 2005; 20:551-61; PMID:16307919; http://dx.doi.org/10.1016/j.molcel.2005.09.024
39. Wu Y, Xiao S, Zhu XD. MRE11-RAD50-NBS1 and ATM function as co-mediators of TRF1 in telomere length control. Nat Struct Mol Biol 2007; 14:832-40; PMID:17694070; http://dx.doi.org/10.1038/nsmb1286
40. O'Sullivan RJ, Karlseder J. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 2010; 11:171-81; PMID:20125188
41. Fraser M, Harding SM, Zhao H, Coackley C, Durocher D, Bristow RG. MRE11 promotes AKT phosphorylation in direct response to DNA double-strand breaks. Cell Cycle 2011; 10:2218-32; PMID:21623170; http://dx.doi.org/10.4161/cc.10.13. 16305
42. Bashir T, Pagan JK, Busino L, Pagano M. Phosphorylation of Ser72 is dispensable for Skp2 assembly into an active SCF ubiquitin ligase and its subcellular localization. Cell Cycle 2010; 9:971-4; PMID:20160477; http://dx.doi.org/10.4161/cc.9.5.10914
43. Boutonnet C, Tanguay PL, Julien C, Rodier G, Coulombe P, Meloche S. Phosphorylation of Ser72 does not regulate the ubiquitin ligase activity and sub-cellular localization of Skp2. Cell Cycle 2010; 9:975-9; PMID:20160482; http://dx.doi.org/10.4161/cc.9.5.10915
44. Wang H, Cui J, Bauzon F, Zhu L. A comparison between Skp2 and FOXO1 for their cytoplasmic localization by Akt1. Cell Cycle 2010; 9:1021-2; PMID:20160512; http://dx.doi.org/10.4161/cc.9.5.10916
45. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253-67; PMID:18354415; http://dx.doi.org/10.1038/nrc2347
46. Starostina NG, Kipreos ET. Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors. Trends Cell Biol 2012; 22:33-41; PMID:22154077; http://dx.doi.org/10.1016/j.tcb.2011.10.004